D
Dyne Therapeutics, Inc. DYN
$10.05 $0.202.03% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 60.64M 53.79M 62.48M 56.02M 50.18M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 440.93M 397.10M 343.89M 314.47M 271.08M
Operating Income -440.93M -397.10M -343.89M -314.47M -271.08M
Income Before Tax -412.89M -367.13M -317.42M -294.51M -257.60M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -412.89 -367.13 -317.42 -294.51 -257.60
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -412.89M -367.13M -317.42M -294.51M -257.60M
EBIT -440.93M -397.10M -343.89M -314.47M -271.08M
EBITDA -439.04M -395.31M -342.21M -312.84M -269.47M
EPS Basic -3.86 -3.59 -3.35 -3.56 -3.58
Normalized Basic EPS -2.41 -2.25 -2.10 -2.23 -2.24
EPS Diluted -3.86 -3.59 -3.35 -3.56 -3.58
Normalized Diluted EPS -2.41 -2.25 -2.10 -2.23 -2.24
Average Basic Shares Outstanding 426.65M 405.28M 376.42M 335.83M 296.05M
Average Diluted Shares Outstanding 426.65M 405.28M 376.42M 335.83M 296.05M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --